Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,466 | 26,190 | 71,329 | 21,897 | 25,703 |
| Marketable Securities | 279,799 | 128,841 | 95,367 | 82,219 | 25,996 |
| TOTAL | $340,235 | $160,634 | $169,691 | $106,026 | $52,022 |
| Non-Current Assets | |||||
| PPE Net | 46 | 42 | 47 | 48 | 14 |
| Other Non-Current Assets | 98 | 426 | 79 | 48 | 2,084 |
| TOTAL | $144 | $468 | $126 | $96 | $2,098 |
| Total Assets | $340,379 | $161,102 | $169,817 | $106,122 | $54,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,853 | 6,203 | 794 | 440 | 569 |
| Accrued Expenses | 1,562 | 924 | 522 | 1,225 | 500 |
| TOTAL | $6,450 | $11,644 | $3,514 | $2,724 | $2,412 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 181 | 203 | 209 | 216 | 165 |
| TOTAL | $181 | $203 | $209 | $216 | $165 |
| Total Liabilities | $6,631 | $11,847 | $3,723 | $2,940 | $2,577 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,145 | 1,141 | 975 | 974 | 809 |
| Common Shares | 3 | 2 | 2 | 2 | N/A |
| Retained earnings | -76,862 | -64,994 | -50,049 | -40,889 | -30,362 |
| Other shareholders' equity | 51 | -66 | -18 | -100 | 74,561 |
| TOTAL | $333,748 | $149,255 | $166,094 | $103,182 | $51,543 |
| Total Liabilities And Equity | $340,379 | $161,102 | $169,817 | $106,122 | $54,120 |